| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |